Home › Funds › Caption Management, LLC › XENE

Caption Management, LLC position in XENE

XENON PHARMACEUTICALS INC · Health Care

Caption Management, LLC reported holding 728,000 shares of XENE (XENON PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$43.9M, representing 0.75% of its reported portfolio and ranking #25 among its reported holdings. Caption Management, LLC has disclosed XENE holdings in 9 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)728.00K sh
Reported value held$43.94M
Portfolio Weight0.75%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Caption Management, LLC's XENE position evolved

Caption Management, LLC first disclosed a stake in XENE in Q3 2023 at 9,500 shares (US$325K). The position peaked in Q2 2026 at 728,000 shares, worth US$43.9M. Across 9 filings, Caption Management, LLC increased the stake 5 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 728,000 shares valued at US$43.9M — an increase of 372,300 shares quarter over quarter.. Notable position changes include a 1907% increase in Q4 2023 (shares fell 7% over the following quarter), a 383% increase in Q4 2025 (shares rose 30% over the following quarter), a 105% increase in Q2 2026 (shares fell 38% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 9.50K $324.52K New
Q4 2023 190.70K $8.78M Add
Q1 2024 248.30K $10.69M Add
Q1 2025 256.70K $8.61M New
Q2 2025 100.94K $3.16M Reduce
Q3 2025 60.00K $2.41M Reduce
Q4 2025 290.00K $13.00M Add
Q1 2026 355.70K $20.68M Add
Q2 2026 728.00K $43.94M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About XENE and 13F data

XENE (XENON PHARMACEUTICALS INC) is a Health Care company. 43 other funds we track also report a position in XENE — the largest reported positions include Avoro Capital Advisors LLC (US$348.7M), Polar Capital Holdings Plc (US$275.9M), DRIEHAUS CAPITAL MANAGEMENT LLC (US$266.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding XENE

All XENE fund holders →

FAQ

How long has Caption Management, LLC held XENE?

Caption Management, LLC has disclosed XENE holdings in 9 of the last 12 reported quarters, going back to Q3 2023.

What is Caption Management, LLC's current position in XENE?

As of Q2 2026, Caption Management, LLC holds 728.00K shares of XENE (XENON PHARMACEUTICALS INC), valued at $43.94M, representing 0.75% of its reported portfolio and ranking #25.

Has Caption Management, LLC been buying or selling XENE?

In the latest 13F filing (Q2 2026), Caption Management, LLC increased its position in XENE. The position peaked in Q2 2026 at 728.00K shares.

Which other funds hold XENE?

Other major institutional holders of XENE include Avoro Capital Advisors LLC, Polar Capital Holdings Plc, DRIEHAUS CAPITAL MANAGEMENT LLC, among 43 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.